Scarlet
PrivateLast Round
Series B
Oct 12, 2026
Est. Valuation
$70M
Total Funding Raised
$76.76M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Scarlet is a healthcare technology company that provides certification services for software and AI-driven medical devices in the EU and UK markets.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Compliance & Risk, Medical AI, RegTech
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scarlet Comparables
Compare Scarlet with similar companies based on industry and business-model similarity.
Scarlet Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 12, 2026 | ||||
| Series A | Jun 1, 2024 | ||||
| Seed | Aug 1, 2022 | ||||
| Pre Seed | Jan 1, 2021 |
Scarlet Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creandum | Series A, Series B, Seed |
| Notion Capital | Series B |
| Kindred Capital | Series A, Seed, Series B, Pre Seed |
| Atomico | Series B, Series A |
| Headline | Series B |
| Entrepreneurs First | Series A, Seed, Series B, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 12, 2026
$50M round led by Headline.
- Jun 13, 2026
Added Skin Analytics Ltd as a customer.
Recent news
Latest coverage and updates
- expands_offices_inOct 12, 2026
Scarlet plans to expand in the United States
- recognized_asOct 12, 2026
Scarlet says the US Food and Drug Administration recognizes it as a Third Party Review Organisation in United States
- hiresOct 12, 2026
Scarlet is to add Nancy Xiao McLaughlin to its board
- receives_financingOct 12, 2026
Scarlet raises $50M in Series B financing led by Headline in October 2026 to build a global AI certification body, expand its expert team, and increase its footprint in the United States and APAC.
- attends_eventOct 1, 2026
Scarlet attends the Medical Technology Association of Australia's RegConnect Summit 2026 in Australia in Sep '26, where its Head of Public Affairs says manufacturers need greater clarity and lead time as regulatory frameworks evolve.
Scarlet Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Scarlet's valuation, stock price, and market status.
Is Scarlet a public or private company?
Scarlet is a private company.
What is the current stock price of Scarlet?
Scarlet is a private company, so its shares have no public market price. Caplight tracks Scarlet's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scarlet worth (valuation)?
Scarlet's valuation is estimated at $70.0M based on funding round data.
Can I buy Scarlet stock?
Scarlet shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scarlet's last funding round?
Scarlet's most recent funding round was Series B on October 12, 2026.
Who are the main investors in Scarlet?
Key investors in Scarlet include Creandum, Atomico, Headline.
Will Scarlet IPO soon?
No public IPO plans have been announced for Scarlet.
How can I track Scarlet secondary market activity?
Caplight tracks bids, offers, and trades in Scarlet's shares on secondary markets.